facebook
twitter
rss
account
search
search
 

Fake marijuana helps Alzheimer's disease

Aug. 20, 2003 at 3:48 PM   |   Comments

CHICAGO, Aug. 20 (UPI) -- Study results suggest dronabinol, a synthetic version of THC, the active ingredient of marijuana, may reduce agitation for Alzheimer's sufferers.

According to data presented Wednesday at the annual meeting of the International Psychogeriatric Association, dronabinol, marketed under the trade name Marinol, also improves appetite in Alzheimer's patients.

Dronabinol is the only cannabinoid approved by the U.S. Food and Drug Administration and is indicated for the treatment of anorexia in patients with HIV/AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy.

"Our research suggests dronabinol may reduce agitation and improve appetite in patients with Alzheimer's disease, when traditional therapies are not successful," said Joshua Shua-Haim, lead investigator in the study and medical director of the Meridian Institute for Aging, a continuum of senior health programs and services in New Jersey.

© 2003 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Newfoundland fossil is earliest evidence of muscled animals
2
Tech industry All Stars developing 'Star Trek'-style communication badges
3
Latvia boasts world's first net for migrating bats
4
Study: gamblers' brains not unlike those of pigeons
5
Neanderthals and humans interacted for thousands of years
Trending News
Video
x
Feedback